Five‐Year Outcomes of Continuous Zoledronic Acid vs. Denosumab Treatment in Older Men with High Fracture Risk: Effects on Bone Density Improvement and Risk Factor Analysis of Improvement of Bone Density and Incidence of New Fracture

Title
Five‐Year Outcomes of Continuous Zoledronic Acid vs. Denosumab Treatment in Older Men with High Fracture Risk: Effects on Bone Density Improvement and Risk Factor Analysis of Improvement of Bone Density and Incidence of New Fracture
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-28
DOI
10.1002/jcph.2378

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started